| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Clinical PET Centre, Genitourinary Medicine and Haemophilia Centre, Guys and St. Thomas Hospital Trust, St. Thomas' Hospital, London, United Kingdom
Correspondence: For correspondence contact: Michael J. O'Doherty, MD, FRCP, The Clinical PET Centre, Guys and St. Thomas Hospital Trust, St. Thomas' Hospital, London SE1 7EH, United Kingdom.
ABSTRACT
The use of PET scanning in patients with human immunodeficiency virus infection and fever of unknown origin, confusion and/or weight loss was investigated. Methods: Eighty patients were examined using PET. Fifty-seven patients had half-body scans with [18F]flu-orodeoxyglucose (FDG), and 23 patients had brain studies per formed with FDG. Fourteen patients also had [11C]methionine studies (2 chest, 1 abdomen and 11 brain) performed. Results: Thirteen patients with lymphoma had the extent of the disease clearly identified in both nodal and extranodal sites. Patients with a variety of infections (Cryptococcus neoformans, Pseudomonas aeruginosa, Mycobacterium tuberculosis and Mycobacterium avium intracellu lare) had disease localized for appropriate biopsy or sampling procedures. A half-body FDG-PET scan had a sensitivity of 92% and a specificity of 94% for localization of focal pathology that needed treatment.High uptake of FDG (greater than liver) had a positive predictive value for pathology needing treatment of 95%. FDG brain studies showed that 16 patients with CD4 T-lymphocyte counts less than 200 cells/ml had reduced cortical uptake compared with that in basal ganglia. FDG scans were abnormal in all 19 patients with focal space occupying lesions identified by magnetic resonance scans. The standardized uptake values (SUVs) over cerebral lesions due to toxoplasma were in the range of 0.14–3.7 (13 patients) and due to lymphoma were in the range of 3.9-8.7 (6 patients). Three more patients with progressive multifocal leukoen-cephalopathy had SUVs in the range of 1.0-1.5 over the lesions. Another patient had a low-grade oligodendroglioma (SUV = 2.9). Carbon-11-methionine uptake also was high in patients with cere bral lymphoma but did not add to the discrimination between toxoplasmosis and lymphoma in these patients obtained with the FDG scan. Conclusion: In hospitals with access to PET facilities, FDG scanning allows the rapid evaluation of the whole body, including the brain, of patients with human immunodeficiency virus infection, with a report potentially available within 4 hr of injection. Sites of infection and tumor were identified, and discrimination between cerebral pathologies was possible.
Key Words: human immunodeficiencyvirus • PET • fluorodeoxyglu-cose • methionine • infection • tumor
This article has been cited by other articles:
|
|
 |
|
  N. Kosaka, T. Tsuchida, H. Uematsu, H. Kimura, H. Okazawa, and H. Itoh 18F-FDG PET of Common Enhancing Malignant Brain Tumors Am. J. Roentgenol., June 1, 2008; 190(6): W365 - W369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kumar, S. Basu, D. Torigian, V. Anand, H. Zhuang, and A. Alavi Role of Modern Imaging Techniques for Diagnosis of Infection in the Era of 18F-Fluorodeoxyglucose Positron Emission Tomography Clin. Microbiol. Rev., January 1, 2008; 21(1): 209 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Love, M. B. Tomas, G. G. Tronco, and C. J. Palestro FDG PET of Infection and Inflammation RadioGraphics, September 1, 2005; 25(5): 1357 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Love and C. J. Palestro Radionuclide Imaging of Infection J. Nucl. Med. Technol., June 1, 2004; 32(2): 47 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y F Tai and P Piccini Applications of positron emission tomography (PET) in neurology J. Neurol. Neurosurg. Psychiatry, May 1, 2004; 75(5): 669 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Rohren, T. G. Turkington, and R. E. Coleman Clinical Applications of PET in Oncology Radiology, May 1, 2004; 231(2): 305 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N A Sibtain and R J S Chinn Imaging of the central nervous system in HIV infection Imaging, February 1, 2002; 14(1): 48 - 59. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J H Rees, N Balakas, A Agathonikou, S F Hain, G Giovanonni, C P Panayiotopoulos, M Luxsuwong, and T Revesz Primary diffuse leptomeningeal gliomatosis simulating tuberculous meningitis J. Neurol. Neurosurg. Psychiatry, January 1, 2001; 70(1): 120 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-J. von Giesen, C. Antke, H. Hefter, F. Wenserski, R. J. Seitz, and G. Arendt Potential Time Course of Human Immunodeficiency Virus Type 1-Associated Minor Motor Deficits: Electrophysiologic and Positron Emission Tomography Findings Arch Neurol, November 1, 2000; 57(11): 1601 - 1607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ammassari, A. Cingolani, P. Pezzotti, A. De Luca, R. Murri, M. L. Giancola, L. M. Larocca, and A. Antinori AIDS-related focal brain lesions in the era of highly active antiretroviral therapy Neurology, October 24, 2000; 55(8): 1194 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. W. Lee, V. Antonacci, S. Tilak, J. D. Fuller, and T. P. Cooley Intracranial Mass Lesions: Sequential Thallium and Gallium Scintigraphy in Patients with AIDS Radiology, May 1, 1999; 211(2): 507 - 512. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
